Open AccessAntidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
Author(s) -
Donadon,
Massimiliano Balbi,
Michela Ghersetti,
Silvia Grazioli,
Antonio Perciaccante,
Della Valentina G,
Rita Gardenal,
Dal Mas M,
Pietro Casarin,
Giorgio Zanette,
Cesare Miranda
Publication year - 2009
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.15.2506
Subject(s) - medicine , metformin , diabetes mellitus , hepatocellular carcinoma , gastroenterology , cirrhosis , type 2 diabetes mellitus , odds ratio , univariate analysis , insulin , multivariate analysis , endocrinology
To explore the association between hepatocellular carcinoma (HCC) and type 2 diabetes mellitus, describe the temporal relations between the onset of diabetes and the development of HCC and evaluate the possible effects of antidiabetic therapy on HCC risk.